Pituitary carcinoma containing gonadotropins: Treatment by radical excision and cytotoxic chemotherapy: Case report

Ian E. McCutcheon, Daniel R. Pieper, Gregory N. Fuller, Robert S. Benjamin, Keith E. Friend, Robert F. Gagel

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

OBJECTIVE AND IMPORTANCE: Pituitary carcinomas are extremely rare. Cases reported in the medical literature in the 20th century included tumors that produced adrenocorticotropic hormone, prolactin, growth hormone, and/or thyrotropin. CLINICAL PRESENTATION: Here we present a 22-year-old woman with a pituitary carcinoma that was immunohistochemically positive for luteinizing hormone and follicle-stimulating hormone at both the primary and metastatic sites. The patient exhibited elevated serum levels of α-subunit. INTERVENTION: The patient had experienced failure of previous treatments, including standard surgery and radiotherapy, and presented to us for radical resection of the tumor, with exenteration of the involved cavernous sinus. She was pretreated with cytotoxic chemotherapy and continued to receive this therapy after surgery. CONCLUSION: This is the only documented case of a gonadotropin-staining pituitary carcinoma for which hormone production was proven in both the primary and metastatic tumors. Many benign 'nonsecreting' pituitary adenomas actually produce subclinical amounts of gonadotropins, and malignant nonfunctional pituitary neoplasms may do the same.

Original languageEnglish (US)
Pages (from-to)1233-1240
Number of pages8
JournalNeurosurgery
Volume46
Issue number5
DOIs
StatePublished - May 2000

Keywords

  • Follicle-stimulating hormone
  • Gonadotropins
  • Luteinizing hormone
  • Pituitary carcinoma

ASJC Scopus subject areas

  • Surgery
  • Clinical Neurology

Fingerprint

Dive into the research topics of 'Pituitary carcinoma containing gonadotropins: Treatment by radical excision and cytotoxic chemotherapy: Case report'. Together they form a unique fingerprint.

Cite this